Drawing for LAEVITA

USPTO serial 79434389

LAEVITA

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BARRESE, TAYLOR ANN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with LAEVITA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Deborah J Peckham

Deborah J Peckham Barclay Damon LLP160 Federal Street, Suite 1001Boston, MA 02110United States

Goods and services

ClassDescriptionStatusFirst use
009Computer hardware and recorded operating system software sold as a unit for use in monitoring and controlling cosmetic, surgical, and medical apparatus, namely, monitoring laser power and laser beam collimation, and calculating and controlling dosage of laser energy to targeted tissuesACTIVE—
010Optical fiber cables in the nature of lasers for medical and surgical use in the field of gynecology and for the treatment of gynecological, urinary disorders, genitourinary syndrome of menopause and aesthetic skin rejuvenation; medical devices for monitoring and controlling medical laser systems comprising laser sources, diode lasers, optical fibers, guiding devices, catheters, cannulas, handpieces, aspirators, and applicators with integrated recorded operating system software sold as a unit, for cosmetic, surgical and medical use, namely, for the treatment of gynecological, urinary disorders, genitourinary syndrome of menopause and aesthetic skin rejuvenation in the field of gynecology; medical devices and apparatus used in gynecological treatments, namely, laser systems comprising laser sources, diode lasers, optical fibers, guiding devices, catheters, cannulas, handpieces, aspirators, and applicators for vaginal health and therapeutic devices for pelvic care, namely, vaginal dilators; medical dual-wavelength laser systems comprising laser sources, diode lasers, optical fibers, guiding devices, catheters, cannulas, handpieces, aspirators, and applicators for vaginal rejuvenation and intimate health; medical apparatus for improving vaginal health, addressing conditions, particularly, vaginal atrophy, urinary incontinence, genitourinary syndrome of menopause and aesthetic skin rejuvenation; optical and laser-powered systems for cosmetic, surgical, and medical use, comprising laser sources, diode lasers, optical fibers, guiding devices, catheters, cannulas, handpieces, aspirators, and applicators; medical and surgical apparatus structural components for guiding and delivering treatments, designed for use in cosmetic, surgical, and therapeutic procedures, namely for the treatment of gynecological, urinary disorders, genitourinary syndrome of menopause and aesthetic skin rejuvenationACTIVE—
044Medical services provided through laser therapy and optical fiber technologies for vaginal rejuvenation and intimate health; Providing medical treatments aimed at improving vaginal health, and addressing conditions, particularly, vaginal atrophy, urinary incontinence and genitourinary syndrome of menopause performed using advanced laser and fiber-assisted systemsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 20, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 20, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 15, 2026GPNXNOTIFICATION PROCESSED BY IB—
Oct 15, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 14, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 30, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 30, 2026OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 18, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 18, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Sep 18, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 18, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 14, 2026ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Sep 8, 2026PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 20, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 21, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 21, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 21, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2026RFNPREFUSAL PROCESSED BY IB—
Jan 21, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 21, 2026RFRRREFUSAL PROCESSED BY MPU—
Dec 10, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 9, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 5, 2025DOCKASSIGNED TO EXAMINER—
Nov 30, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 30, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 30, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 30, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 30, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 10, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 9, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance